---
title: "Dupixent (dupilumab) in atopic dermatitis: Specific populations questions"
description: "Specific populations questions on Dupixent (dupilumab) in atopic dermatitis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: Can Dupixent be used during pregnancy? Can Dupixent be used while breastfeeding? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/specific-populations"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Dupixent (dupilumab) in atopic dermatitis: Specific populations questions

Manufacturer: sanofi-aventis U.S. LLC; Regeneron Pharmaceuticals, Inc.  
Prescribing information: [Dupixent](https://www.regeneron.com/downloads/dupixent_fpi.pdf)

## Specific populations

<a id="dupixent-pregnancy"></a>

### Can Dupixent be used during pregnancy?

> “Pregnancy: A pregnancy exposure registry monitors pregnancy outcomes in women exposed to DUPIXENT during pregnancy. Available data from case reports and case series with DUPIXENT use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. Human IgG antibodies are known to cross the placental barrier; therefore, DUPIXENT may be transmitted from the mother to the developing fetus.”

Source: [DUPIXENT: Adult Clinical Trial Safety Profile, captured 2026-11-12](https://www.dupixenthcp.com/atopicdermatitis/efficacy-safety/safety-clinical-trial#:~:text=Pregnancy%3A%20A%20pregnancy%20exposure%20registry,mother%20to%20the%20developing%20fetus.)

<a id="dupixent-breastfeeding"></a>

### Can Dupixent be used while breastfeeding?

> “Lactation: There are no data on the presence of DUPIXENT in human milk, the effects on the breastfed infant, or the effects on milk production. Maternal IgG is known to be present in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for DUPIXENT and any potential adverse effects on the breastfed child from DUPIXENT or from the underlying maternal condition.”

Source: [DUPIXENT: Adult Clinical Trial Safety Profile, captured 2026-11-12](https://www.dupixenthcp.com/atopicdermatitis/efficacy-safety/safety-clinical-trial#:~:text=Lactation%3A%20There%20are%20no%20data,from%20the%20underlying%20maternal%20condition.)

## Related pages
- [Medical information: Dupixent (dupilumab): Atopic dermatitis](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis)
- [Indication](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/safety)
- [Drug interactions](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/access-and-coverage)
- [Guidelines](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/guidelines)
